Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use

NCT02121535 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: T80/A5 mg FDC tablet
DRUG: T80/A5 mg FDC tablet
DRUG: H12.5 mg tablet
DRUG: T80/A5/H12.5 ng FDC tablet
DRUG: H12.5 mf tablet
DRUG: T80/A5/H12.5 mg FDC tablet

Sponsor

Boehringer Ingelheim